Hypoxia-inducible factor 1α inhibitor induces cell death via suppression of BCR-ABL1 and Met expression in BCR-ABL1 tyrosine kinase inhibitor sensitive and resistant chronic myeloid leukemia cells

Chronic myeloid leukemia (CML) has a markedly improved prognosis with the use of breakpoint cluster region-abelson 1 (BCR-ABL1) tyrosine kinase inhibitors (BCR-ABL1 TKIs). However, approximately 40% of patients are resistant or intolerant to BCR-ABL1 TKIs. Hypoxia-inducible factor 1α (HIF-1α) is a h...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsubaki, Masanobu, Takeda, Tomoya, Matsuda, Takuya, Kimura, Akihiro, Tanaka, Remi, Nagayoshi, Sakiko, Hoshida, Tadafumi, Tanabe, Kazufumi, Nishida, Shozo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Biochemistry and Molecular Biology 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978365/
https://www.ncbi.nlm.nih.gov/pubmed/36195570
http://dx.doi.org/10.5483/BMBRep.2022-0095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978365/
https://www.ncbi.nlm.nih.gov/pubmed/36195570
http://dx.doi.org/10.5483/BMBRep.2022-0095

Ejemplares similares